BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 25931827)

  • 1. The genetic basis of familial adenomatous polyposis and its implications for clinical practice and risk management.
    Leoz ML; Carballal S; Moreira L; Ocaña T; Balaguer F
    Appl Clin Genet; 2015; 8():95-107. PubMed ID: 25931827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial adenomatous polyposis.
    Half E; Bercovich D; Rozen P
    Orphanet J Rare Dis; 2009 Oct; 4():22. PubMed ID: 19822006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of APC and MUTYH mutations to familial adenomatous polyposis susceptibility in Hungary.
    Papp J; Kovacs ME; Matrai Z; Orosz E; Kásler M; Børresen-Dale AL; Olah E
    Fam Cancer; 2016 Jan; 15(1):85-97. PubMed ID: 26446593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetics of familial adenomatous polyposis (FAP) and MutYH-associated polyposis (MAP).
    Claes K; Dahan K; Tejpar S; De Paepe A; Bonduelle M; Abramowicz M; Verellen C; Franchimont D; Van Cutsem E; Kartheuser A
    Acta Gastroenterol Belg; 2011 Sep; 74(3):421-6. PubMed ID: 22103048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of familial adenomatous polyposis and MUTYH-associated polyposis; new insights.
    Aelvoet AS; Buttitta F; Ricciardiello L; Dekker E
    Best Pract Res Clin Gastroenterol; 2022; 58-59():101793. PubMed ID: 35988966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MUTYH Associated Polyposis (MAP).
    Poulsen ML; Bisgaard ML
    Curr Genomics; 2008 Sep; 9(6):420-35. PubMed ID: 19506731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis.
    Nielsen M; Hes FJ; Nagengast FM; Weiss MM; Mathus-Vliegen EM; Morreau H; Breuning MH; Wijnen JT; Tops CM; Vasen HF
    Clin Genet; 2007 May; 71(5):427-33. PubMed ID: 17489848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal Adenomatous Polyposis: Heterogeneity of Susceptibility Gene Mutations and Phenotypes in a Cohort of Italian Patients.
    Marabelli M; Molinaro V; Abou Khouzam R; Berrino E; Panero M; Balsamo A; Venesio T; Ranzani GN
    Genet Test Mol Biomarkers; 2016 Dec; 20(12):777-785. PubMed ID: 27705013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative role of APC and MUTYH mutations in the pathogenesis of familial adenomatous polyposis.
    Pezzi A; Roncucci L; Benatti P; Sassatelli R; Varesco L; Di Gregorio C; Venesio T; Pedroni M; Maffei S; Reggiani Bonetti L; Borsi E; Ferrari M; Martella P; Rossi G; Ponz De Leon M
    Scand J Gastroenterol; 2009; 44(9):1092-100. PubMed ID: 19593690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c.1227_1228dupGG (p.Glu410Glyfs), a frequent variant in Tunisian patients with MUTYH associated polyposis.
    Kdissa A; Brusgaard K; Ksiaa M; Golli L; Hallara O; Ousager LB; Manoubi W; Seghaier RB; Adala L; Halleb Y; Saad A; Hmila F; Gribaa M
    Cancer Genet; 2020 Jan; 240():45-53. PubMed ID: 31739127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline hypermethylation of the APC promoter is not a frequent cause of familial adenomatous polyposis in APC/MUTYH mutation negative families.
    Romero-Giménez J; Dopeso H; Blanco I; Guerra-Moreno A; Gonzalez S; Vogt S; Aretz S; Schwartz S; Capella G; Arango D
    Int J Cancer; 2008 Mar; 122(6):1422-5. PubMed ID: 18027849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MUTYH-associated polyposis - variability of the clinical phenotype in patients with biallelic and monoallelic MUTYH mutations and report on novel mutations.
    Morak M; Laner A; Bacher U; Keiling C; Holinski-Feder E
    Clin Genet; 2010 Oct; 78(4):353-63. PubMed ID: 20618354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of inherited genetic variants in colorectal polyposis syndromes.
    Short E; Sampson J
    Adv Genet; 2019; 103():183-217. PubMed ID: 30904095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetic basis of colonic adenomatous polyposis syndromes.
    Talseth-Palmer BA
    Hered Cancer Clin Pract; 2017; 15():5. PubMed ID: 28331556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and clinical study of familial adenomatous polyposis for genetic testing and management.
    Li G; Tamura K; Yamamoto Y; Sashio H; Utsunomiya J; Yamamura T; Shimoyama T; Furuyama J
    J Exp Clin Cancer Res; 1999 Dec; 18(4):519-29. PubMed ID: 10746979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mutations and phenotypic associations identified through APC, MUTYH, NTHL1, POLD1, POLE gene analysis in Indian Familial Adenomatous Polyposis cohort.
    Khan N; Lipsa A; Arunachal G; Ramadwar M; Sarin R
    Sci Rep; 2017 May; 7(1):2214. PubMed ID: 28533537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel APC mutations in Czech and Slovak FAP families: clinical and genetic aspects.
    Stekrova J; Sulova M; Kebrdlova V; Zidkova K; Kotlas J; Ilencikova D; Vesela K; Kohoutova M
    BMC Med Genet; 2007 Apr; 8():16. PubMed ID: 17411426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appropriate Management of Attenuated Familial Adenomatous Polyposis: Report of a Case and Review of the Literature.
    Sokic-Milutinovic A
    Dig Dis; 2019; 37(5):400-405. PubMed ID: 30836352
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.